2
Total investments
0
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2018
At the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) we build next-generation light-based measuring tools operating at the cellular and molecular level. We seek to understand and quantify those nano-sized processes that impact both the health and condition of the living body, as well as of other dynamic biological systems.
We take a trans-disciplinary approach to our research, drawing from a pool of expertise in fields as diverse as biology, engineering, physics, chemistry, materials science and medicine, aiming to create the biomedical and biosensing tools of the future.
Advanced lasers, optical fibres, nanoprobes, chemical sensors and state-of-the-art imaging and microscopy techniques, these are just some of the photonic (light-based) methodologies we employ to develop our tools and to better understand the activity taking place deep within the cellular environment.
Our research has wide-reaching implications for medical evaluations and scientific discoveries. By offering insights into the nanoscale processes that underpin all life, an opportunity to explore and extend the limits of science is being undertaken, in areas ranging from persistent pain, to vascular health, to fertility and reproductive success.
Additionally, our advanced sensing tools are able to be used across the veterinary care, food production, agricultural and manufacturing sectors. The creation of our deployable bio-devices offers real-time molecular analysis, supporting quality monitoring and assessment.
A $40m initiative, our Centre consists of approximately 150 researchers located at three outstanding Universities—The University of Adelaide, Macquarie University and RMIT University—all fully equipped with world class laboratories and facilities.
Visit our web site to find out more.
Board Member
Oct 2018
Australian Sickle Cell Advocacy Inc is a not for profit organisation supporting people living with Sickle Cell Disease (SCD) in Australia.
It is the peak body in Australia looking out for people affected by this disease.
Our head office is based in Melbourne with chapters in Western Australia, New South Wales and South Australia. Soon we will have chapters in all Australian States.
Our main objectives stands out to raise awareness about this disease that is considered a rare disease in Australia.
We are also tirelessly looking out for services that are missing in these commuity of people. We have been approaching different policy makers to ensure SCD is recognised just like any other chronic disease in Australia.
To ensure that all medications that are used to manage this disease are accessible for all. To have screening available in Australia for SCD. To ensure that healthcare workers are aware of disease.
These and more objectives, see our website for more. Join us to change the face of Sickle Cell Disease in Australia.
Experience · 10 entries
All (10)
Investments (2)
Founder (4)
Board (2)
2021
Member, Policy Committee
Jul 2021
Science & Technology Australia (STA) is Australia’s peak body in science and technology. Representing more than 90,000 scientists and technologists working across all scientific disciplines, STA is a respected and influential contributor to debate on public policy. Our mission is to bring together scientists, governments, industry and the broader community to advance the role, reputation and impact of science and technology across the nation.
2018
Board Member
Oct 2018
At the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) we build next-generation light-based measuring tools operating at the cellular and molecular level. We seek to understand and quantify those nano-sized processes that impact both the health and condition of the living body, as well as of other dynamic biological systems.
We take a trans-disciplinary approach to our research, drawing from a pool of expertise in fields as diverse as biology, engineering, physics, chemistry, materials science and medicine, aiming to create the biomedical and biosensing tools of the future.
Advanced lasers, optical fibres, nanoprobes, chemical sensors and state-of-the-art imaging and microscopy techniques, these are just some of the photonic (light-based) methodologies we employ to develop our tools and to better understand the activity taking place deep within the cellular environment.
Our research has wide-reaching implications for medical evaluations and scientific discoveries. By offering insights into the nanoscale processes that underpin all life, an opportunity to explore and extend the limits of science is being undertaken, in areas ranging from persistent pain, to vascular health, to fertility and reproductive success.
Additionally, our advanced sensing tools are able to be used across the veterinary care, food production, agricultural and manufacturing sectors. The creation of our deployable bio-devices offers real-time molecular analysis, supporting quality monitoring and assessment.
A $40m initiative, our Centre consists of approximately 150 researchers located at three outstanding Universities—The University of Adelaide, Macquarie University and RMIT University—all fully equipped with world class laboratories and facilities.
Visit our web site to find out more.
Board Member
Oct 2018
Australian Sickle Cell Advocacy Inc is a not for profit organisation supporting people living with Sickle Cell Disease (SCD) in Australia.
It is the peak body in Australia looking out for people affected by this disease.
Our head office is based in Melbourne with chapters in Western Australia, New South Wales and South Australia. Soon we will have chapters in all Australian States.
Our main objectives stands out to raise awareness about this disease that is considered a rare disease in Australia.
We are also tirelessly looking out for services that are missing in these commuity of people. We have been approaching different policy makers to ensure SCD is recognised just like any other chronic disease in Australia.
To ensure that all medications that are used to manage this disease are accessible for all. To have screening available in Australia for SCD. To ensure that healthcare workers are aware of disease.
These and more objectives, see our website for more. Join us to change the face of Sickle Cell Disease in Australia.
2017
Australasian Associate Editor, Gene Therapy Journal
Jul 2017
Be Part of Progress - together we bring greater understanding to the world
Springer Nature is one of the leading publishers of research in the world. We publish the largest number of journals and books and are a pioneer in open research. Through our leading brands, trusted for more than 180 years, we provide technology-enabled products, platforms and services that help researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning. We are proud to be part of progress, working together with the communities we serve to share knowledge and bring greater understanding to the world.
Global key facts:
Established for over 180 years
Nearly 10,000 colleagues
200 offices in over 40 countries on all continents
World’s largest academic book publisher
Publisher of Nature, the world’s most influential journal
First company to publish more than 1 million Open Access articles
Key brands and imprints:
Springer Nature is home to some of the best-known names in research, health and educational publishing. Every day, around the globe, our brands reach millions of people.
Nature Portfolio
Springer
BMC
Discover
Palgrave Macmillan
Apress
Macmillan Education
Springer Health+
Springer Medizin
Research Square
J.B. Metzler
BSL Media & Learning
Adis
2014
Science in Australia Gender Equity (SAGE) Expert Advisory Group
Mar 2014
Based at the National Heritage-listed Shine Dome in Canberra, the Australian Academy of Science is a Fellowship of more than 520 of the nation's top scientists who live and work in Australia and around the world. New Fellows are elected annually for their personal contributions to science. We were founded on 16 February 1954 by Australian Fellows of the Royal Society of London, with the distinguished physicist Sir Mark Oliphant as founding President.
Our mission is to provide independent, authoritative and influential scientific advice, promote international scientific engagement, build public awareness and understanding of science, and champion, celebrate and support excellence in Australian science.
Show all 10 entries ↓
Similar investors
Startup investors in Australia
Investor lists
Lists that match Dr Marguerite's portfolio
- Startup investors in Australia738 investors






